Background: The correlation of the angiotensin-converting enzyme insertion/deletion polymorphism with essential hypertension shown in previous studies is controversial, and the responses of hypertensive patients with different angiotensin-converting enzyme genotypes to treatment with an angiotensin-converting enzyme inhibitor merits investigation.
Methods: Eighty-nine patients with essential hypertension and 102 normotensive subjects were included in this study. All subjects were genotyped by polymerase chain reaction for the insertion/deletion polymorphism of the angiotensin-converting enzyme gene. Blood pressure was measured before and after taking Benazepril 10 mg, once daily, for 2 months.
Results: The genotype and allele frequencies were similar (X2 = 0.64, P = .73; x2 = 0.36, P = .55, respectively). The reduction of both systolic and diastolic blood pressure in the DD genotype was significantly greater than in the II genotype (10.13 ± 4.91 vs 5.37 ± 2.79, P < .01; 7.47 + 3.50 vs 4.71 ± 2.40, P < .05, respectively).
Conclusions: No significant association of angiotensin-converting enzyme gene polymorphism with essential hypertension was found. Angiotensin-converting enzyme gene polymorphism might be related to the antihypertensive response to an angiotensin-converting enzyme inhibitor in hypertensive patients.
1. Barley J, Blackwood A, Miller M, et al. Angiotensin converting enzyme gene I/D polymorphism, blood pressure and the renin-angiotensin system in Caucasian and AfroCaribbean peoples. J Hum Hypertens10:31-31, 1996
2.
2. Duru K, Farrow S, Wang JM, et al. Frequency of a deletion polymorphism in the gene for angiotensin converting enzyme is increased in African-Americans with hypertension. Am J Hypertens7:759-759, 1994
3.
3. Vassilikioti S, Doumas M, Petidis K, et al. Angiotensin converting enzyme gene polymorphism is not related to essential hypertension in a Greek population. Am J Hypertens9:700-700, 1996
4.
4. Schmidt S, van Hooft IM, Grobbee DE, et al. Polymorphism of the angiotensin I converting enzyme gene is apparently not related to high blood pressure: Dutch Hypertension and Offspring Study. J Hypertens11:345-345, 1993
5.
5. Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest86:1343-1343, 1990
6.
6. Danser AH, Schalekamp MA, Bax WA, et al. Angiotensinconverting enzyme in the human heart: Effect of the deletion/insertion polymorphism. Circulation92:1387-1387, 1995
7.
7. Baudin B. Angiotensin I-converting enzyme gene polymorphism and drug response. Clin Chem Lab Med38:853-853, 2000
8.
8. The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure (JNC V). Arch Intern Med153:154-154, 1993
9.
9. Tiret L, Rigat B, Visvikis S, et al. Evidence, from combined segregation and likage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet51:197-197, 1992
10.
10. Chiang FT, Lai ZP, Chern TH, et al. Lack of association of the angiotensin converting enzyme polymorphism with essential hypertension in a Chinese population. Am J Hypertens10:197-197, 1997
11.
11. Cao W, Ling SS, Zhang QC, et al. Angiotensin-converting enzyme gene polymorphism in untreated essential hypertension and response to angiotensin converting enzyme inhibitors. Acta Pharmaceutica Sinica34:655-655, 1999
12.
12. Ishigami T, Iwamota T, Tamura K, et al. Angiotensin I converting enzyme (ACE) gene polymorphism and essential hypertension in Japan. Ethnic difference of ACE genotype. Am J Hypertension8:95-95, 1995
13.
13. Jian M, Huang J, Qi J, et al. Polymorphism of angiotensin I converting enzyme gene in the older Chinese: linked to ambulatory blood pressure levels and circadian blood pressure rhythm. Int J Cardiol55:33-33, 1996
14.
14. Chiang FT, Chem TH, Lai ZP, et al. Age- and gender- dependent association of the angiotensin-converting enzyme gene with essential hypertension in a Chinese population. J Hum Hypertens10:823-823, 1996
15.
15. SL Wu, SR Feng, KB Li, et al. Correlation of angiotensin converting enzyme genes type with the effect of antihypertensive treatment by captopril. Chin J Hypertens9:296-296, 2001
16.
16. Stavroulakis GA, Makris TK, Krespi PG, et al. Predicting response to chronic antihypertensive treatment with fosinopril: The role of angiotensin-converting enzyme gene polymorphism. Cardiovasc Drugs Ther14:427-427, 2000
17.
17. Ueda S, Meredith PA, Morton JJ, et al. ACE (I/D) genotype as a predictor of the magnitude and duration of the response to an ACE inhibitor drug (Enalaprilat) in humans. Circulation98:2148-2148, 1998
18.
18. Danser AH, Derkx FH, Hense HW, et al. Angiotensinogen (M235T) and angiotensin-converting enzyme (LID) polymorphisms in association with plasma renin and prorenin levels. J Hypertens16:1879-1879, 1998
19.
19. Prasad A, Narayanan S, Husain S, et al. Insertion-deletion polymorphism of the ACE gene modulates reversibility of endothelial dysfunction with ACE inhibition. Circulation102:35-35, 2000
20.
20. Buikema H, Pinto YM, Rooks G, et al. The deletion polymorphism of the angiotensin-converting enzyme gene is related to phenotypic differences in human arteries. Eur Heart J17:787-787, 1996
21.
21. Ueda S, Elliott HL, Morton JJ, et al. Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme. Hypertension25:1266-1266, 1995
22.
22. Brown NJ, Blais C, Gandhi SK, et al. ACE insertion/deletion genotype affects bradykinin metabolism. J Cardiovasc Pharmacol32:373-373, 1998
23.
23. Gainer JV, Morrow JD, Loveland A, et al. Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects. N Engl J Med339:1285-1285, 1998
24.
24. Bouaziz H, Joulin Y, Safar M, et al. Effects of bradykinin B2 receptor antagonism on the hypotensive effects of ACE inhibition. Br J Pharmacol113:717-717, 1994
25.
25. Barbe F, Su JB, Guyene TT, et al. Bradykinin pathway is involved in acute hemodynamic effects of enalaprilat in dogs with heart failure. Am J Physiol270:H1985-H1985, 1996
26.
26. Morris BJ, Zee RYL, Schrader A. Different frequencies of angiotensin-converting enzyme genotypes in older hypertensive individuals. J Clin Invest94:1085-1085, 1994
27.
27. Dieguez-Lucena JL, Aranda-Lara P, Ruiz-Galdon M, et al. Angiotensin I-converting enzyme genotypes and angiotensin (receptors. Response to therapy. Hypertension28:98-98, 1996
